A novel composition comprises a compound of Formula 1
1
the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers, prodrugs, or mixtures thereof. The composition is of particular utility in the treatment of kinase-implicated disorders.
一种新型组合物包括公式11的化合物,其中药用可接受的盐,
水合物,溶剂合物,晶体形式,对映异构体,前药或其混合物。该组合物在治疗激酶相关疾病方面具有特殊的实用性。